Cancer Diagnostics Market by Current Industry Status, Growth Opportunities, Top Players and Forecast To 2030

The MarketWatch News Department was not involved in the creation of this content. Feb 05,…

The MarketWatch News Department was not involved in the creation of this content.

Feb 05, 2021 (Market Insight Reports) —
Canada – The global Cancer Diagnostics market size is projected to hit USD 261.34 billion by 2030 and expected to grow at a compound annual growth rate (CAGR) of 8.4% from 2021 to 2030.

Precedence Research answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Cancer Diagnostics market.

The report delivers an unbiased and comprehensive analysis of the on-going trends, prospects/high growth areas and market dynamics which would aid the stakeholders to adopt and align their market tactics in line with the existing and forthcoming market dynamics.

Request Coronavirus Impact Analysis on This [email protected] https://www.precedenceresearch.com/sample/1194

This report contains a unique mix of perceptible insights and qualitative scrutiny to help businesses accomplish sustainable growth. This research study helps to understand industry action with comprehensive data revealing where companies are receiving their revenues and with what products and with which technology. Company profiles includes detailed business overview, product portfolio offerings, new strategies adopted by them, financial analysis and recent developments.

This report also offers impact analysis of COVID-19 outbreak on the market dynamics and future opportunities to overcome from the crises. COVD-19 pandemic is first a health and humanitarian crisis, and businesses are rapidly altering. While the crisis unfolds, industry leaders should prepare for what is approaching subsequent. The new-fangled reality taking shape is made of intricacy, ambiguity and opportunities. To acclimatize and thrive, market participants must accelerate and become robust and agile.

The report also includes PORTER’s five force model, SWOT analysis, corporate and business models strategies of leading industry participants. Cancer Diagnostics market report also recognizes value chain analysis to comprehend the cost differentiation, pricing models to deliver a competitive advantage to the predominant and upcoming market entrants.

Get Customization on this Research [email protected] https://www.precedenceresearch.com/customization/1194

Key Player

  • Agilent Technologies, Inc.

  • Thermo Fisher Scientific, Inc.

  • Illumina, Inc.

  • Becton, Dickinson and Company

  • GE Healthcare

  • QIAGEN N.V.

  • Abbott Laboratories, Inc.

  • Roche Diagnostics

  • Siemens Healthcare

  • Philips Healthcare

  • R. Bard, Inc.

  • Others

Segments Covered in the Report

This research report estimates revenue growth at global, regional, and country levels and offers an analysis of present industry trends in every sub-segment from 2017 to 2030.This research study analyzes market thoroughly by classifying global cancer diagnostics market report on the basis of different parameters including type of test type, application and region as follows:

By Test Type

  • Laboratory Tests

  • Genetic Tests

  • Imaging

  • Endoscopy

  • Biopsy

  • Others (barium enema)

By Application

  • Breast Cancer

  • Colorectal Cancer

  • Cervical Cancer

  • Lung Cancer

  • Prostate Cancer

  • Skin Cancer

  • Blood Cancer

  • Kidney Cancer

  • Liver Cancer

  • Pancreatic Cancer

  • Ovarian Cancer

  • Others

By Regional Outlook

  • North America
  • Europe
  • Asia Pacific

    • China

    • India

    • Japan

    • South Korea

  • Rest of the World

Important Highlights of the Report:

  • Historical Revenue of Cancer Diagnostics Market for the Period 2017-2030

  • Market Estimate & Forecast of Cancer Diagnostics Market until 2030

  • Historical Revenue of Cancer Diagnostics Market, By Type for the Period 2017-2030

  • Market Estimate & Forecast of Cancer Diagnostics Market, By Type until 2030

  • Historical Revenue of Cancer Diagnostics, By Applications for the Period 2017-2030

  • Market Estimate & Forecast of Cancer Diagnostics Market, By Applications until 2030

  • Historical Revenue of Cancer Diagnostics Market, By Country for the Period 2017-2030

  • Market Estimate & Forecast of Cancer Diagnostics Market, By Country until 2030

  • Market Drivers, Challenges and Opportunities

  • Key Performance Indicators

  • Competitive Landscape (Manufacturers Revenue, Share and Benchmarking)

Motives to Purchase:

  • Save and decrease time for conducting entry-level research by recognizing the growth, size, foremost players and sectors in the global Cancer Diagnostics market

  • Develop/adapt development tactics by means of significant growth openings in established and evolving markets

  • Examine exhaustive global market tendencies and viewpoint plus factors pushing the market

  • Augment the decision-making procedure by understanding the approaches that support profitable interest with respect to segmentation, products, pricing and distribution

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Cancer Diagnostics Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Cancer Diagnostics Market

5.1. Covid-19: Cancer Diagnostics Industry Impact
5.2. Cancer Diagnostics Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Cancer Diagnostics Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Cancer Diagnostics Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Cancer Diagnostics Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Driver 1
6.1.1.2. Driver 2
6.1.2. Market Restraints
6.1.2.1. Restraint 1
6.1.3. Market Opportunities
6.1.3.1. Opportunity 1
6.1.3.2. Opportunity 2

Chapter 7. Global Cancer Diagnostics Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Cancer Diagnostics Market Revenue by Market Players (2015-2020)
7.1.1.2. Cancer Diagnostics Market Revenue Market Share by Market Players (2015-2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Product Type Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Cancer Diagnostics Market, By Product Type

8.1. Cancer Diagnostics Market, by Product Type, 2016-2027
8.1.1. Laboratory Tests
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Genetic Tests
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Imaging
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Endoscopy
8.1.5. Biopsy
8.1.6. Others (barium enema)

Chapter 9. Global Cancer Diagnostics Market, By Application

9.1. Cancer Diagnostics Market, by Application, 2016-2027
9.1.1. Breast Cancer
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Colorectal Cancer
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Cervical Cancer
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Lung Cancer
9.1.4.1. Market Revenue and Forecast (2016-2027)
9.1.5. Prostate Cancer
9.1.6. Skin Cancer
9.1.7. Blood Cancer
9.1.8. Kidney Cancer
9.1.9. Liver Cancer
9.1.10. Pancreatic Cancer
9.1.11. Ovarian Cancer
9.1.12. Others

Chapter 10. Global Cancer Diagnostics Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue Forecast by Product Type(2016-2027)
10.1.2. Market Revenue Forecast by Application (2016-2027)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2016-2027)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2016-2027)
10.2. Europe
10.2.1. Market Revenue Forecast by Product Type(2016-2027)
10.2.2. Market Revenue Forecast by Application (2016-2027)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2016-2027)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2016-2027)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2016-2027)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2016-2027)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Product Type(2016-2027)
10.3.2. Market Revenue Forecast by Application (2016-2027)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2016-2027)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2016-2027)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2016-2027)
10.4. LATAM
10.4.1. Market Revenue Forecast by Product Type(2016-2027)
10.4.2. Market Revenue Forecast by Application (2016-2027)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2016-2027)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2016-2027)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Product Type(2016-2027)
10.5.2. Market Revenue Forecast by Application (2016-2027)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2016-2027)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2016-2027)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2016-2027)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2016-2027)

Chapter 11. Company Profiles

11.1. Agilent Technologies, Inc.
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Application
11.1.3. Revenue, Price, and Gross Margin (2015-2020)
11.1.4. Recent Developments and Strategies
11.2. Thermo Fisher Scientific, Inc.
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin (2015-2020)
11.2.4. Recent Developments and Strategies
11.3. Illumina, Inc.
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin (2015-2020)
11.3.4. Recent Developments and Strategies
11.4. Becton, Dickinson and Company
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin (2015-2020)
11.4.4. Recent Developments and Strategies
11.5. GE Healthcare
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin (2015-2020)
11.5.4. Recent Developments and Strategies
11.6. QIAGEN N.V.
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin (2015-2020)
11.6.4. Recent Developments and Strategies
11.7. Abbott Laboratories, Inc.
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin (2015-2020)
11.7.4. Recent Developments and Strategies
11.8. Roche Diagnostics
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin (2015-2020)
11.8.4. Recent Developments and Strategies
11.9. Siemens Healthcare
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin (2015-2020)
11.9.4. Recent Developments and Strategies
11.10. Philips Healthcare
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, Application
11.10.3. Revenue, Price, and Gross Margin (2015-2020)
11.10.4. Recent Developments and Strategies

Chapter 12. Appendix

12.1. About Us
12.2. Glossary of Terms

You can place an order or ask any questions, please feel free to contact at [email protected] | +1 774 402 6168

The Final Report will cover the impact analysis of COVID-19.

Download This Exclusive Research Report, Click [email protected] https://www.precedenceresearch.com/checkout/1194

COMTEX_380256506/2599/2021-02-05T05:54:17

Is there a problem with this press release? Contact the source provider Comtex at [email protected] You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.